CA2741964A1

CA2741964A1 - Novel tools for the production of glycosylated proteins in host cells

Novel tools for the production of glycosylated proteins in host cells Download PDF

Info

Publication number: CA2741964A1
Authority: CA; Canada
Prior art keywords: cell; activity; glycoprotein; type; type activity
Prior art date: 2008-10-31
Legal status : Abandoned

Application number

CA2741964A

Other languages

English (en)

French (fr)

Inventor

Jonne Helenius

Christine Neupert

Markus Aebi

Farnoush Parsaie Nasab

Alexander Daniel Frey

Current Assignee

Lonza AG

Original Assignee

Lonza AG

Priority date

2008-10-31

Filing date

2009-10-31

Publication date

2010-05-06

2009-10-31 Application filed by Lonza AG filed Critical Lonza AG

2010-05-06 Publication of CA2741964A1 publication Critical patent/CA2741964A1/en

Status Abandoned legal-status Critical Current

Links

238000004519 manufacturing process Methods 0.000 title claims abstract description 25
102000035122 glycosylated proteins Human genes 0.000 title abstract description 6
108091005608 glycosylated proteins Proteins 0.000 title abstract description 6
210000004027 cell Anatomy 0.000 claims abstract description 778
108090000623 proteins and genes Proteins 0.000 claims abstract description 312
102000003886 Glycoproteins Human genes 0.000 claims abstract description 237
108090000288 Glycoproteins Proteins 0.000 claims abstract description 237
102000004169 proteins and genes Human genes 0.000 claims abstract description 158
150000004676 glycans Chemical group 0.000 claims abstract description 120
239000000203 mixture Substances 0.000 claims abstract description 66
108060003951 Immunoglobulin Proteins 0.000 claims abstract description 15
102000018358 immunoglobulin Human genes 0.000 claims abstract description 15
230000001225 therapeutic effect Effects 0.000 claims abstract description 15
230000000694 effects Effects 0.000 claims description 561
101001010097 Shigella phage SfV Bactoprenol-linked glucose translocase Proteins 0.000 claims description 177
150000007523 nucleic acids Chemical class 0.000 claims description 134
102000039446 nucleic acids Human genes 0.000 claims description 131
108020004707 nucleic acids Proteins 0.000 claims description 131
238000000034 method Methods 0.000 claims description 123
102000004357 Transferases Human genes 0.000 claims description 115
108090000992 Transferases Proteins 0.000 claims description 115
239000013598 vector Substances 0.000 claims description 91
102000004190 Enzymes Human genes 0.000 claims description 88
108090000790 Enzymes Proteins 0.000 claims description 88
150000002482 oligosaccharides Chemical class 0.000 claims description 87
150000002632 lipids Chemical class 0.000 claims description 85
125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 85
108010089072 Dolichyl-diphosphooligosaccharide-protein glycotransferase Proteins 0.000 claims description 84
229920001542 oligosaccharide Polymers 0.000 claims description 72
230000014509 gene expression Effects 0.000 claims description 69
125000003729 nucleotide group Chemical group 0.000 claims description 64
239000002773 nucleotide Substances 0.000 claims description 63
239000012634 fragment Substances 0.000 claims description 49
230000003292 diminished effect Effects 0.000 claims description 46
102100022622 Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Human genes 0.000 claims description 40
108010087568 Mannosyltransferases Proteins 0.000 claims description 40
102000006722 Mannosyltransferases Human genes 0.000 claims description 40
230000015572 biosynthetic process Effects 0.000 claims description 40
238000003786 synthesis reaction Methods 0.000 claims description 37
230000001086 cytosolic effect Effects 0.000 claims description 30
101000972916 Homo sapiens Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Proteins 0.000 claims description 27
108010086873 UDP-N-acetylglucosamine transporter Proteins 0.000 claims description 26
102100033778 UDP-N-acetylglucosamine transporter Human genes 0.000 claims description 24
101150104887 ALG11 gene Proteins 0.000 claims description 23
241000222732 Leishmania major Species 0.000 claims description 23
108700023372 Glycosyltransferases Proteins 0.000 claims description 22
150000001413 amino acids Chemical class 0.000 claims description 22
230000005021 gait Effects 0.000 claims description 22
150000002772 monosaccharides Chemical class 0.000 claims description 22
241000223105 Trypanosoma brucei Species 0.000 claims description 21
102100033782 UDP-galactose translocator Human genes 0.000 claims description 21
108010075920 UDP-galactose translocator Proteins 0.000 claims description 21
241000222740 Leishmania braziliensis Species 0.000 claims description 20
210000005061 intracellular organelle Anatomy 0.000 claims description 18
230000002194 synthesizing effect Effects 0.000 claims description 18
102100033787 CMP-sialic acid transporter Human genes 0.000 claims description 15
101710150575 CMP-sialic acid transporter Proteins 0.000 claims description 15
108010035265 N-acetylneuraminate synthase Proteins 0.000 claims description 15
102100029954 Sialic acid synthase Human genes 0.000 claims description 15
108010019236 Fucosyltransferases Proteins 0.000 claims description 14
102000006471 Fucosyltransferases Human genes 0.000 claims description 14
101000588377 Homo sapiens N-acylneuraminate cytidylyltransferase Proteins 0.000 claims description 14
102100031349 N-acylneuraminate cytidylyltransferase Human genes 0.000 claims description 14
108010089489 N-acylneuraminate-9-phosphatase Proteins 0.000 claims description 14
102100023906 N-acylneuraminate-9-phosphatase Human genes 0.000 claims description 14
108010069465 N-acylneuraminate-9-phosphate synthase Proteins 0.000 claims description 14
101710091363 UDP-N-acetylglucosamine 2-epimerase Proteins 0.000 claims description 14
108010064886 beta-D-galactoside alpha 2-6-sialyltransferase Proteins 0.000 claims description 14
108010002020 Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Proteins 0.000 claims description 13
101710203794 GDP-fucose transporter Proteins 0.000 claims description 13
102000051366 Glycosyltransferases Human genes 0.000 claims description 13
101710146120 Alpha-(1,6)-fucosyltransferase Proteins 0.000 claims description 12
102100021266 Alpha-(1,6)-fucosyltransferase Human genes 0.000 claims description 12
241000222697 Leishmania infantum Species 0.000 claims description 12
101710119007 GDP-L-fucose synthase Proteins 0.000 claims description 11
102100024515 GDP-L-fucose synthase Human genes 0.000 claims description 11
108010062427 GDP-mannose 4,6-dehydratase Proteins 0.000 claims description 11
102000002312 GDPmannose 4,6-dehydratase Human genes 0.000 claims description 11
102100024296 Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Human genes 0.000 claims description 10
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 10
210000003527 eukaryotic cell Anatomy 0.000 claims description 10
239000001963 growth medium Substances 0.000 claims description 10
210000004962 mammalian cell Anatomy 0.000 claims description 10
101710122990 Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Proteins 0.000 claims description 9
230000003197 catalytic effect Effects 0.000 claims description 9
101150103561 ALG2 gene Proteins 0.000 claims description 8
101150039297 Alg3 gene Proteins 0.000 claims description 8
230000002538 fungal effect Effects 0.000 claims description 8
210000003463 organelle Anatomy 0.000 claims description 8
230000009466 transformation Effects 0.000 claims description 8
ZTOKCBJDEGPICW-UHFFFAOYSA-N Man3GlcNAc2 Natural products OC1C(NC(=O)C)C(O)OC(CO)C1OC1C(NC(C)=O)C(O)C(OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(COC3C(C(O)C(O)C(CO)O3)O)O2)O)C(CO)O1 ZTOKCBJDEGPICW-UHFFFAOYSA-N 0.000 claims description 7
ZTOKCBJDEGPICW-GWPISINRSA-N alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc Chemical compound O[C@@H]1[C@@H](NC(=O)C)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)O2)O)[C@@H](CO)O1 ZTOKCBJDEGPICW-GWPISINRSA-N 0.000 claims description 7
108010044698 beta-N-Acetylglucosaminylglycopeptide beta-1,4-Galactosyltransferase Proteins 0.000 claims description 7
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 6
238000012258 culturing Methods 0.000 claims description 6
101150089325 dpm1 gene Proteins 0.000 claims description 6
239000008194 pharmaceutical composition Substances 0.000 claims description 6
241000223109 Trypanosoma cruzi Species 0.000 claims description 5
201000010099 disease Diseases 0.000 claims description 5
210000003660 reticulum Anatomy 0.000 claims description 5
102100024775 Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase Human genes 0.000 claims description 4
KUYCTNQKTFGPMI-SXHURMOUSA-N Glc(a1-2)Glc(a1-3)Glc(a1-3)Man(a1-2)Man(a1-2)Man(a1-3)[Man(a1-2)Man(a1-3)[Man(a1-2)Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc Chemical compound O[C@@H]1[C@@H](NC(=O)C)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O[C@@H]4[C@@H]([C@@H](O[C@@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)O3)O)O2)O)[C@@H](CO)O1 KUYCTNQKTFGPMI-SXHURMOUSA-N 0.000 claims description 4
241000238631 Hexapoda Species 0.000 claims description 4
241000222727 Leishmania donovani Species 0.000 claims description 4
241000222696 Leishmania guyanensis Species 0.000 claims description 4
241000222734 Leishmania mexicana Species 0.000 claims description 4
241000222736 Leishmania tropica Species 0.000 claims description 4
101150074984 RFT1 gene Proteins 0.000 claims description 4
241000223997 Toxoplasma gondii Species 0.000 claims description 4
239000002671 adjuvant Substances 0.000 claims description 4
238000011282 treatment Methods 0.000 claims description 4
108030001771 Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferases Proteins 0.000 claims description 3
239000003937 drug carrier Substances 0.000 claims description 3
102100037982 Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A Human genes 0.000 claims description 2
230000000779 depleting effect Effects 0.000 claims description 2
230000003467 diminishing effect Effects 0.000 claims description 2
230000001131 transforming effect Effects 0.000 claims description 2
KSEVLWYNDHVCJB-DMZKWVAKSA-N n-[(2r,3r,4r,5s,6r)-2-[(2r,3r,4s,5r)-2-acetamido-6-hydroxy-1-oxo-4-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl Chemical compound O([C@H]([C@H](C=O)NC(=O)C)[C@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H](CO)O[C@@H]1[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O KSEVLWYNDHVCJB-DMZKWVAKSA-N 0.000 claims 2
101710170638 Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A Proteins 0.000 claims 1
102100026349 Beta-1,4-galactosyltransferase 1 Human genes 0.000 claims 1
GRHWEVYJIHXESA-HBHDJDHDSA-N beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->3)-[beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc Chemical compound O[C@@H]1[C@@H](NC(=O)C)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@@H](O)[C@H](O[C@H]4[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O4)O)[C@@H](CO)O3)NC(C)=O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@@H](O)[C@H](O[C@H]4[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O4)O)[C@@H](CO)O3)NC(C)=O)O2)O)[C@@H](CO)O1 GRHWEVYJIHXESA-HBHDJDHDSA-N 0.000 claims 1
WYUKJASPBYYQRJ-VSJOFRJTSA-N beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->3)-[beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-GlcpNAc-(1->4)-beta-D-GlcpNAc Chemical group O[C@@H]1[C@@H](NC(=O)C)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)NC(C)=O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)NC(C)=O)O2)O)[C@@H](CO)O1 WYUKJASPBYYQRJ-VSJOFRJTSA-N 0.000 claims 1
240000004808 Saccharomyces cerevisiae Species 0.000 abstract description 89
230000013595 glycosylation Effects 0.000 abstract description 64
238000006206 glycosylation reaction Methods 0.000 abstract description 64
241000206602 Eukaryota Species 0.000 abstract description 17
210000005260 human cell Anatomy 0.000 abstract description 9
229940072221 immunoglobulins Drugs 0.000 abstract description 7
235000018102 proteins Nutrition 0.000 description 137
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 88
229940088598 enzyme Drugs 0.000 description 86
229940041290 mannose Drugs 0.000 description 79
238000012545 processing Methods 0.000 description 55
239000013612 plasmid Substances 0.000 description 54
102000005572 Cathepsin A Human genes 0.000 description 46
108010059081 Cathepsin A Proteins 0.000 description 46
230000002018 overexpression Effects 0.000 description 42
125000003275 alpha amino acid group Chemical group 0.000 description 40
108020004414 DNA Proteins 0.000 description 35
239000012528 membrane Substances 0.000 description 34
230000012010 growth Effects 0.000 description 33
230000008569 process Effects 0.000 description 33
230000030583 endoplasmic reticulum localization Effects 0.000 description 32
230000004988 N-glycosylation Effects 0.000 description 30
-1 lipid dolichol Chemical class 0.000 description 29
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 27
210000004379 membrane Anatomy 0.000 description 27
108090000765 processed proteins & peptides Proteins 0.000 description 26
238000003556 assay Methods 0.000 description 24
239000002131 composite material Substances 0.000 description 24
239000000758 substrate Substances 0.000 description 24
235000001014 amino acid Nutrition 0.000 description 22
238000012217 deletion Methods 0.000 description 22
230000037430 deletion Effects 0.000 description 22
238000012546 transfer Methods 0.000 description 22
229940024606 amino acid Drugs 0.000 description 21
241000894007 species Species 0.000 description 20
238000012986 modification Methods 0.000 description 19
102000004196 processed proteins & peptides Human genes 0.000 description 19
230000004048 modification Effects 0.000 description 18
229920001184 polypeptide Polymers 0.000 description 18
108090000141 Sialyltransferases Proteins 0.000 description 17
102000003838 Sialyltransferases Human genes 0.000 description 17
108091026890 Coding region Proteins 0.000 description 16
241000282414 Homo sapiens Species 0.000 description 16
230000000295 complement effect Effects 0.000 description 16
230000006870 function Effects 0.000 description 16
101150091482 SLC52A2 gene Proteins 0.000 description 15
108091033319 polynucleotide Proteins 0.000 description 15
102000040430 polynucleotide Human genes 0.000 description 15
239000002157 polynucleotide Substances 0.000 description 15
DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 14
108010015899 Glycopeptides Proteins 0.000 description 14
102000002068 Glycopeptides Human genes 0.000 description 14
108091028043 Nucleic acid sequence Proteins 0.000 description 14
238000004128 high performance liquid chromatography Methods 0.000 description 14
210000005253 yeast cell Anatomy 0.000 description 14
241000235058 Komagataella pastoris Species 0.000 description 13
239000003550 marker Substances 0.000 description 13
101100186924 Escherichia coli neuC gene Proteins 0.000 description 12
210000002421 cell wall Anatomy 0.000 description 12
230000037361 pathway Effects 0.000 description 12
229940070376 protein Drugs 0.000 description 12
SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 11
SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 11
SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 11
241000282412 Homo Species 0.000 description 10
238000006467 substitution reaction Methods 0.000 description 10
235000000346 sugar Nutrition 0.000 description 10
241000233866 Fungi Species 0.000 description 9
210000000349 chromosome Anatomy 0.000 description 9
239000013613 expression plasmid Substances 0.000 description 9
102000045442 glycosyltransferase activity proteins Human genes 0.000 description 9
108700014210 glycosyltransferase activity proteins Proteins 0.000 description 9
210000002288 golgi apparatus Anatomy 0.000 description 9
230000001976 improved effect Effects 0.000 description 9
238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 9
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 8
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 8
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 8
239000002253 acid Substances 0.000 description 8
238000007792 addition Methods 0.000 description 8
108091007497 betacoronavirus-specific marker domains Proteins 0.000 description 8
230000001965 increasing effect Effects 0.000 description 8
108010078791 Carrier Proteins Proteins 0.000 description 7
PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 7
238000004458 analytical method Methods 0.000 description 7
238000013518 transcription Methods 0.000 description 7
230000035897 transcription Effects 0.000 description 7
UQBIAGWOJDEOMN-UHFFFAOYSA-N 2-O-(2-O-(alpha-D-mannopyranosyl)-alpha-D-mannopyranosyl)-D-mannopyranose Natural products OC1C(O)C(CO)OC(O)C1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 UQBIAGWOJDEOMN-UHFFFAOYSA-N 0.000 description 6
102100026348 Beta-1,4-galactosyltransferase 2 Human genes 0.000 description 6
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 6
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 6
241000196324 Embryophyta Species 0.000 description 6
101100186921 Legionella pneumophila subsp. pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513) neuB gene Proteins 0.000 description 6
108010054377 Mannosidases Proteins 0.000 description 6
102000001696 Mannosidases Human genes 0.000 description 6
239000000872 buffer Substances 0.000 description 6
210000004978 chinese hamster ovary cell Anatomy 0.000 description 6
230000007547 defect Effects 0.000 description 6
239000013604 expression vector Substances 0.000 description 6
230000010354 integration Effects 0.000 description 6
238000002372 labelling Methods 0.000 description 6
239000002609 medium Substances 0.000 description 6
239000000600 sorbitol Substances 0.000 description 6
229960002920 sorbitol Drugs 0.000 description 6
235000010356 sorbitol Nutrition 0.000 description 6
230000001629 suppression Effects 0.000 description 6
230000032258 transport Effects 0.000 description 6
108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
101100013695 Caenorhabditis elegans fut-8 gene Proteins 0.000 description 5
102100020746 Dolichol-phosphate mannosyltransferase subunit 1 Human genes 0.000 description 5
102100039371 ER lumen protein-retaining receptor 1 Human genes 0.000 description 5
102000003951 Erythropoietin Human genes 0.000 description 5
108090000394 Erythropoietin Proteins 0.000 description 5
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
101000932202 Homo sapiens Dolichol-phosphate mannosyltransferase subunit 1 Proteins 0.000 description 5
101000812437 Homo sapiens ER lumen protein-retaining receptor 1 Proteins 0.000 description 5
108010076504 Protein Sorting Signals Proteins 0.000 description 5
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 5
230000001413 cellular effect Effects 0.000 description 5
230000002255 enzymatic effect Effects 0.000 description 5
229940105423 erythropoietin Drugs 0.000 description 5
230000004907 flux Effects 0.000 description 5
229930182830 galactose Natural products 0.000 description 5
150000002402 hexoses Chemical class 0.000 description 5
229940027941 immunoglobulin g Drugs 0.000 description 5
238000005621 mannosylation reaction Methods 0.000 description 5
230000035772 mutation Effects 0.000 description 5
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 5
238000002360 preparation method Methods 0.000 description 5
SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 5
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Chemical group OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 4
101100478734 Caenorhabditis elegans stt-3 gene Proteins 0.000 description 4
101150009006 HIS3 gene Proteins 0.000 description 4
101000987586 Homo sapiens Eosinophil peroxidase Proteins 0.000 description 4
PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 4
241000124008 Mammalia Species 0.000 description 4
241001465754 Metazoa Species 0.000 description 4
OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 4
101150011873 Pdcd6 gene Proteins 0.000 description 4
241000235648 Pichia Species 0.000 description 4
101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 4
230000009471 action Effects 0.000 description 4
229910052799 carbon Inorganic materials 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
150000001875 compounds Chemical class 0.000 description 4
210000000172 cytosol Anatomy 0.000 description 4
150000002031 dolichols Chemical class 0.000 description 4
230000004151 fermentation Effects 0.000 description 4
238000010353 genetic engineering Methods 0.000 description 4
102000044890 human EPO Human genes 0.000 description 4
238000003119 immunoblot Methods 0.000 description 4
239000007788 liquid Substances 0.000 description 4
239000000463 material Substances 0.000 description 4
229950006780 n-acetylglucosamine Drugs 0.000 description 4
CERZMXAJYMMUDR-UHFFFAOYSA-N neuraminic acid Natural products NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO CERZMXAJYMMUDR-UHFFFAOYSA-N 0.000 description 4
239000002243 precursor Substances 0.000 description 4
239000013615 primer Substances 0.000 description 4
239000002987 primer (paints) Substances 0.000 description 4
239000000047 product Substances 0.000 description 4
230000010076 replication Effects 0.000 description 4
229940081969 saccharomyces cerevisiae Drugs 0.000 description 4
239000000523 sample Substances 0.000 description 4
230000035945 sensitivity Effects 0.000 description 4
239000000126 substance Substances 0.000 description 4
210000003412 trans-golgi network Anatomy 0.000 description 4
229940035893 uracil Drugs 0.000 description 4
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
241000894006 Bacteria Species 0.000 description 3
108020004705 Codon Proteins 0.000 description 3
108091035707 Consensus sequence Proteins 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
102000005744 Glycoside Hydrolases Human genes 0.000 description 3
108010031186 Glycoside Hydrolases Proteins 0.000 description 3
101000920686 Homo sapiens Erythropoietin Proteins 0.000 description 3
241000170280 Kluyveromyces sp. Species 0.000 description 3
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
108010052285 Membrane Proteins Proteins 0.000 description 3
OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 3
MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 3
SQVRNKJHWKZAKO-LUWBGTNYSA-N N-acetylneuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-LUWBGTNYSA-N 0.000 description 3
108700026244 Open Reading Frames Proteins 0.000 description 3
229910019142 PO4 Inorganic materials 0.000 description 3
108091093037 Peptide nucleic acid Proteins 0.000 description 3
102000000447 Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase Human genes 0.000 description 3
108010055817 Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase Proteins 0.000 description 3
206010035226 Plasma cell myeloma Diseases 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
101150099625 STT3 gene Proteins 0.000 description 3
101100181264 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KTR6 gene Proteins 0.000 description 3
244000288561 Torulaspora delbrueckii Species 0.000 description 3
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
241000251539 Vertebrata <Metazoa> Species 0.000 description 3
238000013459 approach Methods 0.000 description 3
230000001580 bacterial effect Effects 0.000 description 3
230000007812 deficiency Effects 0.000 description 3
239000003623 enhancer Substances 0.000 description 3
238000000855 fermentation Methods 0.000 description 3
230000004927 fusion Effects 0.000 description 3
239000000499 gel Substances 0.000 description 3
230000002068 genetic effect Effects 0.000 description 3
210000004020 intracellular membrane Anatomy 0.000 description 3
230000004807 localization Effects 0.000 description 3
238000001254 matrix assisted laser desorption--ionisation time-of-flight mass spectrum Methods 0.000 description 3
201000000050 myeloid neoplasm Diseases 0.000 description 3
229940060155 neuac Drugs 0.000 description 3
101150081436 ost2 gene Proteins 0.000 description 3
239000010452 phosphate Substances 0.000 description 3
230000002829 reductive effect Effects 0.000 description 3
230000003362 replicative effect Effects 0.000 description 3
125000005629 sialic acid group Chemical group 0.000 description 3
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
238000001228 spectrum Methods 0.000 description 3
239000003381 stabilizer Substances 0.000 description 3
230000014616 translation Effects 0.000 description 3
239000004474 valine Substances 0.000 description 3
238000001262 western blot Methods 0.000 description 3
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
PXBFMLJZNCDSMP-UHFFFAOYSA-N 2-Aminobenzamide Chemical compound NC(=O)C1=CC=CC=C1N PXBFMLJZNCDSMP-UHFFFAOYSA-N 0.000 description 2
CERZMXAJYMMUDR-QBTAGHCHSA-N 5-amino-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosonic acid Chemical compound N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO CERZMXAJYMMUDR-QBTAGHCHSA-N 0.000 description 2
239000004475 Arginine Substances 0.000 description 2
241000228257 Aspergillus sp. Species 0.000 description 2
TXCIAUNLDRJGJZ-BILDWYJOSA-N CMP-N-acetyl-beta-neuraminic acid Chemical compound O1[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(=O)C)[C@@H](O)C[C@]1(C(O)=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(N=C(N)C=C2)=O)O1 TXCIAUNLDRJGJZ-BILDWYJOSA-N 0.000 description 2
101100478237 Caenorhabditis elegans ost-1 gene Proteins 0.000 description 2
241000222120 Candida <Saccharomycetales> Species 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
102000004127 Cytokines Human genes 0.000 description 2
108090000695 Cytokines Proteins 0.000 description 2
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
MVMSCBBUIHUTGJ-GDJBGNAASA-N GDP-alpha-D-mannose Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H]1O)O)N1C=2N=C(NC(=O)C=2N=C1)N)OP(O)(=O)OP(O)(=O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O MVMSCBBUIHUTGJ-GDJBGNAASA-N 0.000 description 2
101150039256 GMT1 gene Proteins 0.000 description 2
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
102000006771 Gonadotropins Human genes 0.000 description 2
108010086677 Gonadotropins Proteins 0.000 description 2
108010050904 Interferons Proteins 0.000 description 2
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
241000222722 Leishmania <genus> Species 0.000 description 2
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
239000004472 Lysine Substances 0.000 description 2
102000018697 Membrane Proteins Human genes 0.000 description 2
102100026933 Myelin-associated neurite-outgrowth inhibitor Human genes 0.000 description 2
SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 description 2
FDJKUWYYUZCUJX-KVNVFURPSA-N N-glycolylneuraminic acid Chemical compound OC[C@H](O)[C@H](O)[C@@H]1O[C@](O)(C(O)=O)C[C@H](O)[C@H]1NC(=O)CO FDJKUWYYUZCUJX-KVNVFURPSA-N 0.000 description 2
241000235061 Pichia sp. Species 0.000 description 2
101100457678 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MNN10 gene Proteins 0.000 description 2
241000235088 Saccharomyces sp. Species 0.000 description 2
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
239000004473 Threonine Substances 0.000 description 2
108091023040 Transcription factor Proteins 0.000 description 2
108091007498 Transmembrane domain 2 Proteins 0.000 description 2
241000223259 Trichoderma Species 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
241000223093 Trypanosoma sp. Species 0.000 description 2
101150043933 VRG4 gene Proteins 0.000 description 2
241000700605 Viruses Species 0.000 description 2
241000235015 Yarrowia lipolytica Species 0.000 description 2
241000490645 Yarrowia sp. Species 0.000 description 2
LQEBEXMHBLQMDB-UHFFFAOYSA-N [[5-(2-amino-6-oxo-3h-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] (3,4,5-trihydroxy-6-methyloxan-2-yl) hydrogen phosphate Chemical compound OC1C(O)C(O)C(C)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C3=C(C(N=C(N)N3)=O)N=C2)O1 LQEBEXMHBLQMDB-UHFFFAOYSA-N 0.000 description 2
238000002835 absorbance Methods 0.000 description 2
238000009825 accumulation Methods 0.000 description 2
238000005903 acid hydrolysis reaction Methods 0.000 description 2
239000004480 active ingredient Substances 0.000 description 2
230000002730 additional effect Effects 0.000 description 2
235000004279 alanine Nutrition 0.000 description 2
108010039255 alpha 1,6-mannosyltransferase Proteins 0.000 description 2
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
239000003146 anticoagulant agent Substances 0.000 description 2
229940127219 anticoagulant drug Drugs 0.000 description 2
239000000427 antigen Substances 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
235000009697 arginine Nutrition 0.000 description 2
229960003121 arginine Drugs 0.000 description 2
235000009582 asparagine Nutrition 0.000 description 2
229960001230 asparagine Drugs 0.000 description 2
125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 2
235000003704 aspartic acid Nutrition 0.000 description 2
229960005261 aspartic acid Drugs 0.000 description 2
230000008901 benefit Effects 0.000 description 2
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
229960000074 biopharmaceutical Drugs 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
229960000182 blood factors Drugs 0.000 description 2
239000006227 byproduct Substances 0.000 description 2
210000004899 c-terminal region Anatomy 0.000 description 2
238000004364 calculation method Methods 0.000 description 2
239000004202 carbamide Substances 0.000 description 2
150000001720 carbohydrates Chemical class 0.000 description 2
108020001778 catalytic domains Proteins 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 description 2
238000010367 cloning Methods 0.000 description 2
230000004186 co-expression Effects 0.000 description 2
229940000425 combination drug Drugs 0.000 description 2
239000002299 complementary DNA Substances 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
235000018417 cysteine Nutrition 0.000 description 2
230000007423 decrease Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000013461 design Methods 0.000 description 2
238000001514 detection method Methods 0.000 description 2
238000011161 development Methods 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
239000008121 dextrose Substances 0.000 description 2
108010088016 dolichyl-phosphate beta-D-mannosyltransferase Proteins 0.000 description 2
230000008030 elimination Effects 0.000 description 2
238000003379 elimination reaction Methods 0.000 description 2
239000000727 fraction Substances 0.000 description 2
108091006104 gene-regulatory proteins Proteins 0.000 description 2
102000034356 gene-regulatory proteins Human genes 0.000 description 2
239000008103 glucose Substances 0.000 description 2
235000013922 glutamic acid Nutrition 0.000 description 2
239000004220 glutamic acid Substances 0.000 description 2
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
239000002622 gonadotropin Substances 0.000 description 2
229940094892 gonadotropins Drugs 0.000 description 2
230000009643 growth defect Effects 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
239000005556 hormone Substances 0.000 description 2
238000009396 hybridization Methods 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
230000005847 immunogenicity Effects 0.000 description 2
238000009655 industrial fermentation Methods 0.000 description 2
230000003834 intracellular effect Effects 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
238000002955 isolation Methods 0.000 description 2
229960000310 isoleucine Drugs 0.000 description 2
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
230000014759 maintenance of location Effects 0.000 description 2
238000004949 mass spectrometry Methods 0.000 description 2
108020004999 messenger RNA Proteins 0.000 description 2
230000037230 mobility Effects 0.000 description 2
HNQXDLYBFNWFEE-VHZSLYHRSA-N n-[(2r,3r,4r,5s,6r)-2-[(2r,3r,4s,5r)-2-acetamido-5-[(2r,3s,4s,5r,6r)-5-hydroxy-6-(hydroxymethyl)-3,4-bis[[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]oxy-1-oxo-4-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] Chemical compound O([C@H]([C@H](C=O)NC(=O)C)[C@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H](CO[C@@H]1[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@@H]1[C@H]([C@@H](O[C@@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1)O[C@@H]1[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O HNQXDLYBFNWFEE-VHZSLYHRSA-N 0.000 description 2
239000003960 organic solvent Substances 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
239000008188 pellet Substances 0.000 description 2
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
238000007747 plating Methods 0.000 description 2
230000004481 post-translational protein modification Effects 0.000 description 2
238000009790 rate-determining step (RDS) Methods 0.000 description 2
230000009467 reduction Effects 0.000 description 2
108010074916 ribophorin Proteins 0.000 description 2
238000013207 serial dilution Methods 0.000 description 2
239000000243 solution Substances 0.000 description 2
230000004936 stimulating effect Effects 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
239000003826 tablet Substances 0.000 description 2
230000008685 targeting Effects 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
229960000103 thrombolytic agent Drugs 0.000 description 2
230000002537 thrombolytic effect Effects 0.000 description 2
238000013519 translation Methods 0.000 description 2
238000009966 trimming Methods 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
108700026220 vif Genes Proteins 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
SBKVPJHMSUXZTA-MEJXFZFPSA-N (2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-5-amino-2-[[2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-4-methylsulfanylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 SBKVPJHMSUXZTA-MEJXFZFPSA-N 0.000 description 1
INOZZBHURUDQQR-AJNGGQMLSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-(1h-imidazol-5-yl)propanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-4-methylpentanoic acid Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 INOZZBHURUDQQR-AJNGGQMLSA-N 0.000 description 1
MVMSCBBUIHUTGJ-UHFFFAOYSA-N 10108-97-1 Natural products C1=2NC(N)=NC(=O)C=2N=CN1C(C(C1O)O)OC1COP(O)(=O)OP(O)(=O)OC1OC(CO)C(O)C(O)C1O MVMSCBBUIHUTGJ-UHFFFAOYSA-N 0.000 description 1
ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
PZUPAGRIHCRVKN-UHFFFAOYSA-N 5-[5-[3,4-dihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]-5-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound OCC1OC(O)C(O)C(O)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(COC4C(C(O)C(O)CO4)O)O3)O)C(COC3C(C(O)C(O)CO3)O)O2)O)C(COC2C(C(O)C(O)CO2)O)O1 PZUPAGRIHCRVKN-UHFFFAOYSA-N 0.000 description 1
101150078509 ADH2 gene Proteins 0.000 description 1
101150026777 ADH5 gene Proteins 0.000 description 1
108020005296 Acid Ceramidase Proteins 0.000 description 1
102000006772 Acid Ceramidase Human genes 0.000 description 1
102000007469 Actins Human genes 0.000 description 1
108010085238 Actins Proteins 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
108030001769 Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferases Proteins 0.000 description 1
108030002342 Alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferases Proteins 0.000 description 1
102400000068 Angiostatin Human genes 0.000 description 1
108010079709 Angiostatins Proteins 0.000 description 1
240000005528 Arctium lappa Species 0.000 description 1
241001523626 Arxula Species 0.000 description 1
102100022146 Arylsulfatase A Human genes 0.000 description 1
102100031491 Arylsulfatase B Human genes 0.000 description 1
241000235349 Ascomycota Species 0.000 description 1
241000228212 Aspergillus Species 0.000 description 1
241000131314 Aspergillus candidus Species 0.000 description 1
241000131965 Aspergillus carneus Species 0.000 description 1
241000228193 Aspergillus clavatus Species 0.000 description 1
101100460671 Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC 167) norA gene Proteins 0.000 description 1
241001225321 Aspergillus fumigatus Species 0.000 description 1
241000351920 Aspergillus nidulans Species 0.000 description 1
241000228245 Aspergillus niger Species 0.000 description 1
240000006439 Aspergillus oryzae Species 0.000 description 1
241000203233 Aspergillus versicolor Species 0.000 description 1
241000151861 Barnettozyma salicaria Species 0.000 description 1
241000221198 Basidiomycota Species 0.000 description 1
241000680806 Blastobotrys adeninivorans Species 0.000 description 1
102100036850 C-C motif chemokine 23 Human genes 0.000 description 1
TXCIAUNLDRJGJZ-UHFFFAOYSA-N CMP-N-acetyl neuraminic acid Natural products O1C(C(O)C(O)CO)C(NC(=O)C)C(O)CC1(C(O)=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(N=C(N)C=C2)=O)O1 TXCIAUNLDRJGJZ-UHFFFAOYSA-N 0.000 description 1
101100327917 Caenorhabditis elegans chup-1 gene Proteins 0.000 description 1
101100478989 Caenorhabditis elegans swp-1 gene Proteins 0.000 description 1
101100207042 Caenorhabditis elegans unc-94 gene Proteins 0.000 description 1
244000197813 Camelina sativa Species 0.000 description 1
241000222122 Candida albicans Species 0.000 description 1
241000847666 Candida corydali Species 0.000 description 1
241000222128 Candida maltosa Species 0.000 description 1
102000004171 Cathepsin K Human genes 0.000 description 1
108090000625 Cathepsin K Proteins 0.000 description 1
108010036867 Cerebroside-Sulfatase Proteins 0.000 description 1
108010012236 Chemokines Proteins 0.000 description 1
102000019034 Chemokines Human genes 0.000 description 1
241000177202 Chimonobambusa utilis Species 0.000 description 1
102100024539 Chymase Human genes 0.000 description 1
108090000227 Chymases Proteins 0.000 description 1
241001508813 Clavispora lusitaniae Species 0.000 description 1
102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
206010010071 Coma Diseases 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
102100041019 Coordinator of PRMT5 and differentiation stimulator Human genes 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
101150074155 DHFR gene Proteins 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
101001030665 Dictyostelium discoideum GDP-L-fucose synthase Proteins 0.000 description 1
102100024746 Dihydrofolate reductase Human genes 0.000 description 1
101710190124 Dolichol phosphate-mannose mannosyltransferase Proteins 0.000 description 1
101710177360 Dolichol-phosphate mannosyltransferase Proteins 0.000 description 1
102100034583 Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit 1 Human genes 0.000 description 1
102100039216 Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit 2 Human genes 0.000 description 1
102100039486 Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit 4 Human genes 0.000 description 1
102100039104 Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit DAD1 Human genes 0.000 description 1
102100037443 Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit STT3B Human genes 0.000 description 1
102400001368 Epidermal growth factor Human genes 0.000 description 1
101800003838 Epidermal growth factor Proteins 0.000 description 1
YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
101710125177 FAD transporter Proteins 0.000 description 1
108010054218 Factor VIII Proteins 0.000 description 1
102000001690 Factor VIII Human genes 0.000 description 1
108010058643 Fungal Proteins Proteins 0.000 description 1
241000223218 Fusarium Species 0.000 description 1
241001149959 Fusarium sp. Species 0.000 description 1
241000567178 Fusarium venenatum Species 0.000 description 1
101710181121 GDP-mannose-dependent alpha-(1-6)-phosphatidylinositol monomannoside mannosyltransferase Proteins 0.000 description 1
108010043685 GPI-Linked Proteins Proteins 0.000 description 1
102000002702 GPI-Linked Proteins Human genes 0.000 description 1
102100028496 Galactocerebrosidase Human genes 0.000 description 1
108010042681 Galactosylceramidase Proteins 0.000 description 1
108060003306 Galactosyltransferase Proteins 0.000 description 1
102000030902 Galactosyltransferase Human genes 0.000 description 1
239000001828 Gelatine Substances 0.000 description 1
102000004547 Glucosylceramidase Human genes 0.000 description 1
108010017544 Glucosylceramidase Proteins 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
229930186217 Glycolipid Natural products 0.000 description 1
102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
102000038461 Growth Hormone-Releasing Hormone Human genes 0.000 description 1
239000000095 Growth Hormone-Releasing Hormone Substances 0.000 description 1
101000713081 Homo sapiens C-C motif chemokine 23 Proteins 0.000 description 1
101000748895 Homo sapiens Coordinator of PRMT5 and differentiation stimulator Proteins 0.000 description 1
101000609775 Homo sapiens Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit 4 Proteins 0.000 description 1
101000884921 Homo sapiens Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit DAD1 Proteins 0.000 description 1
101000579716 Homo sapiens Protein RFT1 homolog Proteins 0.000 description 1
101500025568 Homo sapiens Saposin-D Proteins 0.000 description 1
101000762128 Homo sapiens Tumor suppressor candidate 3 Proteins 0.000 description 1
108090000144 Human Proteins Proteins 0.000 description 1
102000003839 Human Proteins Human genes 0.000 description 1
108010003272 Hyaluronate lyase Proteins 0.000 description 1
102000009066 Hyaluronoglucosaminidase Human genes 0.000 description 1
102000004867 Hydro-Lyases Human genes 0.000 description 1
108090001042 Hydro-Lyases Proteins 0.000 description 1
108010053927 Iduronate Sulfatase Proteins 0.000 description 1
102000004627 Iduronidase Human genes 0.000 description 1
108010003381 Iduronidase Proteins 0.000 description 1
102000009438 IgE Receptors Human genes 0.000 description 1
108010073816 IgE Receptors Proteins 0.000 description 1
102000014150 Interferons Human genes 0.000 description 1
108010044467 Isoenzymes Proteins 0.000 description 1
SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
241001137872 Leishmania sp. Species 0.000 description 1
244000207740 Lemna minor Species 0.000 description 1
241000163193 Lemyra melli Species 0.000 description 1
102000004882 Lipase Human genes 0.000 description 1
108090001060 Lipase Proteins 0.000 description 1
108010013563 Lipoprotein Lipase Proteins 0.000 description 1
102100022119 Lipoprotein lipase Human genes 0.000 description 1
229920000057 Mannan Polymers 0.000 description 1
102000003792 Metallothionein Human genes 0.000 description 1
108090000157 Metallothionein Proteins 0.000 description 1
241000937897 Meyerozyma caribbica Species 0.000 description 1
101150093077 Mgat2 gene Proteins 0.000 description 1
101150036167 Mgat3 gene Proteins 0.000 description 1
101150086210 Mgat5 gene Proteins 0.000 description 1
101100192157 Mus musculus Psen2 gene Proteins 0.000 description 1
108010027520 N-Acetylgalactosamine-4-Sulfatase Proteins 0.000 description 1
125000003047 N-acetyl group Chemical group 0.000 description 1
102100023315 N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase Human genes 0.000 description 1
108010056664 N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase Proteins 0.000 description 1
SUHQNCLNRUAGOO-UHFFFAOYSA-N N-glycoloyl-neuraminic acid Natural products OCC(O)C(O)C(O)C(NC(=O)CO)C(O)CC(=O)C(O)=O SUHQNCLNRUAGOO-UHFFFAOYSA-N 0.000 description 1
FDJKUWYYUZCUJX-UHFFFAOYSA-N N-glycolyl-beta-neuraminic acid Natural products OCC(O)C(O)C1OC(O)(C(O)=O)CC(O)C1NC(=O)CO FDJKUWYYUZCUJX-UHFFFAOYSA-N 0.000 description 1
108091006036 N-glycosylated proteins Proteins 0.000 description 1
229930193140 Neomycin Natural products 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
101000652829 Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) Exo-alpha-sialidase Proteins 0.000 description 1
241000221961 Neurospora crassa Species 0.000 description 1
101100322982 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) alg-11 gene Proteins 0.000 description 1
101100062121 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cyc-1 gene Proteins 0.000 description 1
101100393179 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) vrg-4 gene Proteins 0.000 description 1
244000061176 Nicotiana tabacum Species 0.000 description 1
235000002637 Nicotiana tabacum Nutrition 0.000 description 1
108091005461 Nucleic proteins Proteins 0.000 description 1
241000320412 Ogataea angusta Species 0.000 description 1
241001452677 Ogataea methanolica Species 0.000 description 1
241000489470 Ogataea trehalophila Species 0.000 description 1
241000826199 Ogataea wickerhamii Species 0.000 description 1
108010035042 Osteoprotegerin Proteins 0.000 description 1
102000008108 Osteoprotegerin Human genes 0.000 description 1
238000010222 PCR analysis Methods 0.000 description 1
101000713179 Papio hamadryas Solute carrier family 52, riboflavin transporter, member 2 Proteins 0.000 description 1
241000530350 Phaffomyces opuntiae Species 0.000 description 1
241000529953 Phaffomyces thermotolerans Species 0.000 description 1
101710177901 Phosphatidyl-myo-inositol mannosyltransferase Proteins 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
241000195887 Physcomitrella patens Species 0.000 description 1
240000000020 Picea glauca Species 0.000 description 1
241000521553 Pichia fermentans Species 0.000 description 1
241000235645 Pichia kudriavzevii Species 0.000 description 1
241000235062 Pichia membranifaciens Species 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
101710091131 Polyprenol-phosphate-mannose-dependent alpha-(1-2)-phosphatidylinositol mannoside mannosyltransferase Proteins 0.000 description 1
101710111973 Polyprenol-phosphate-mannose-dependent alpha-(1-2)-phosphatidylinositol pentamannoside mannosyltransferase Proteins 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
102100028269 Protein RFT1 homolog Human genes 0.000 description 1
101150002896 RNR2 gene Proteins 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
241000714474 Rous sarcoma virus Species 0.000 description 1
102000037062 SLC2 Human genes 0.000 description 1
108091006209 SLC2 Proteins 0.000 description 1
241000235070 Saccharomyces Species 0.000 description 1
241000235072 Saccharomyces bayanus Species 0.000 description 1
101100378834 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ALG2 gene Proteins 0.000 description 1
101100446680 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FLC2 gene Proteins 0.000 description 1
101000604870 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Glycolipid 2-alpha-mannosyltransferase Proteins 0.000 description 1
101100181259 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KTR1 gene Proteins 0.000 description 1
101100181261 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KTR3 gene Proteins 0.000 description 1
101100181262 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KTR4 gene Proteins 0.000 description 1
101100181263 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KTR5 gene Proteins 0.000 description 1
101100457685 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MNN1 gene Proteins 0.000 description 1
101100457679 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MNN11 gene Proteins 0.000 description 1
101100184478 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MNN2 gene Proteins 0.000 description 1
101100184481 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MNN5 gene Proteins 0.000 description 1
101100184484 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MNN9 gene Proteins 0.000 description 1
101100248190 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) RFT1 gene Proteins 0.000 description 1
101100409521 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) RPT6 gene Proteins 0.000 description 1
101100372497 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) VAN1 gene Proteins 0.000 description 1
101100015362 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) VRG4 gene Proteins 0.000 description 1
241001489223 Saccharomycodes Species 0.000 description 1
241001489222 Saccharomycodes ludwigii Species 0.000 description 1
241001489225 Saccharomycopsis capsularis Species 0.000 description 1
241001360381 Saccharomycopsis sp. Species 0.000 description 1
240000003114 Salix fragilis Species 0.000 description 1
241000235350 Schizosaccharomyces octosporus Species 0.000 description 1
241000235347 Schizosaccharomyces pombe Species 0.000 description 1
241000720795 Schizosaccharomyces sp. Species 0.000 description 1
241001123654 Schwanniomyces pseudopolymorphus Species 0.000 description 1
101710142969 Somatoliberin Proteins 0.000 description 1
241000521540 Starmera quercuum Species 0.000 description 1
108091081024 Start codon Proteins 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
102000005488 Thioesterase Human genes 0.000 description 1
102000006601 Thymidine Kinase Human genes 0.000 description 1
108020004440 Thymidine kinase Proteins 0.000 description 1
241000223996 Toxoplasma Species 0.000 description 1
102000040945 Transcription factor Human genes 0.000 description 1
101710162629 Trypsin inhibitor Proteins 0.000 description 1
229940122618 Trypsin inhibitor Drugs 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
102100024248 Tumor suppressor candidate 3 Human genes 0.000 description 1
HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 description 1
102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
206010047505 Visceral leishmaniasis Diseases 0.000 description 1
241000521542 Wickerhamomyces bovis Species 0.000 description 1
241000370136 Wickerhamomyces pijperi Species 0.000 description 1
241000521600 Wickerhamomyces strasburgensis Species 0.000 description 1
241000269368 Xenopus laevis Species 0.000 description 1
108010084455 Zeocin Proteins 0.000 description 1
241000235034 Zygosaccharomyces bisporus Species 0.000 description 1
241000144010 Zygosaccharomyces mellis Species 0.000 description 1
241000235033 Zygosaccharomyces rouxii Species 0.000 description 1
241001030170 Zygosaccharomyces sp. Species 0.000 description 1
GYBNOAFGEKAZTA-QOLULZROSA-N [(6z,10e,14e)-3,7,11,15,19-pentamethylicosa-6,10,14,18-tetraenyl] dihydrogen phosphate Chemical compound OP(=O)(O)OCCC(C)CC\C=C(\C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C GYBNOAFGEKAZTA-QOLULZROSA-N 0.000 description 1
241000420436 [Candida] amphicis Species 0.000 description 1
241000192429 [Candida] atlantica Species 0.000 description 1
241000847667 [Candida] dosseyi Species 0.000 description 1
241000203998 [Candida] fructus Species 0.000 description 1
241000192327 [Candida] membranifaciens Species 0.000 description 1
125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000000654 additive Substances 0.000 description 1
239000008272 agar Substances 0.000 description 1
230000029936 alkylation Effects 0.000 description 1
238000005804 alkylation reaction Methods 0.000 description 1
108010042381 alpha 1,3-mannosyltransferase Proteins 0.000 description 1
108010021726 alpha-1,3-mannosylglycoprotein beta-1,4-N-acetylglucosaminyltransferase Proteins 0.000 description 1
108010034034 alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferase Proteins 0.000 description 1
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
GLEIMNFBCWCWPW-QOTBAUSGSA-N alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc Chemical compound O[C@@H]1[C@@H](NC(=O)C)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)O3)O)O2)O)[C@@H](CO)O1 GLEIMNFBCWCWPW-QOTBAUSGSA-N 0.000 description 1
102000012086 alpha-L-Fucosidase Human genes 0.000 description 1
108010061314 alpha-L-Fucosidase Proteins 0.000 description 1
230000004075 alteration Effects 0.000 description 1
125000000539 amino acid group Chemical group 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
230000003321 amplification Effects 0.000 description 1
239000010775 animal oil Substances 0.000 description 1
101150053991 anp1 gene Proteins 0.000 description 1
230000000692 anti-sense effect Effects 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 description 1
230000002238 attenuated effect Effects 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
239000011324 bead Substances 0.000 description 1
108010073219 beta-1,3-galactosyl-0-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase Proteins 0.000 description 1
108010087667 beta-1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase Proteins 0.000 description 1
MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
102000005936 beta-Galactosidase Human genes 0.000 description 1
102000006995 beta-Glucosidase Human genes 0.000 description 1
108010047754 beta-Glucosidase Proteins 0.000 description 1
108010055059 beta-Mannosidase Proteins 0.000 description 1
102000007478 beta-N-Acetylhexosaminidases Human genes 0.000 description 1
108010085377 beta-N-Acetylhexosaminidases Proteins 0.000 description 1
230000001851 biosynthetic effect Effects 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
239000002775 capsule Substances 0.000 description 1
230000008859 change Effects 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000012707 chemical precursor Substances 0.000 description 1
239000013611 chromosomal DNA Substances 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
229940047120 colony stimulating factors Drugs 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000011109 contamination Methods 0.000 description 1
239000013078 crystal Substances 0.000 description 1
238000007405 data analysis Methods 0.000 description 1
230000002950 deficient Effects 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
108020001096 dihydrofolate reductase Proteins 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
210000002472 endoplasmic reticulum Anatomy 0.000 description 1
230000003511 endothelial effect Effects 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
229940116977 epidermal growth factor Drugs 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000000284 extract Substances 0.000 description 1
238000000605 extraction Methods 0.000 description 1
229960000301 factor viii Drugs 0.000 description 1
230000037433 frameshift Effects 0.000 description 1
230000005714 functional activity Effects 0.000 description 1
102000037865 fusion proteins Human genes 0.000 description 1
108020001507 fusion proteins Proteins 0.000 description 1
101150023212 fut8 gene Proteins 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
108091008053 gene clusters Proteins 0.000 description 1
238000012239 gene modification Methods 0.000 description 1
230000005017 genetic modification Effects 0.000 description 1
230000001295 genetical effect Effects 0.000 description 1
235000013617 genetically modified food Nutrition 0.000 description 1
239000011521 glass Substances 0.000 description 1
150000002334 glycols Chemical class 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
108010041601 histidyl-aspartyl-glutamyl-leucine Proteins 0.000 description 1
230000006801 homologous recombination Effects 0.000 description 1
238000002744 homologous recombination Methods 0.000 description 1
229960000027 human factor ix Drugs 0.000 description 1
229960002773 hyaluronidase Drugs 0.000 description 1
210000004408 hybridoma Anatomy 0.000 description 1
230000028993 immune response Effects 0.000 description 1
208000026278 immune system disease Diseases 0.000 description 1
230000008676 import Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
230000004968 inflammatory condition Effects 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
102000028416 insulin-like growth factor binding Human genes 0.000 description 1
108091022911 insulin-like growth factor binding Proteins 0.000 description 1
230000003993 interaction Effects 0.000 description 1
229940047124 interferons Drugs 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
238000009630 liquid culture Methods 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
150000008146 mannosides Chemical class 0.000 description 1
108010011634 mannosylglycoprotein beta-1,4-N-acetylglucosaminyltransferase Proteins 0.000 description 1
238000001819 mass spectrum Methods 0.000 description 1
230000035800 maturation Effects 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
208000030159 metabolic disease Diseases 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
235000010446 mineral oil Nutrition 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
201000000626 mucocutaneous leishmaniasis Diseases 0.000 description 1
POFWRMVFWIJXHP-UHFFFAOYSA-N n-benzyl-9-(oxan-2-yl)purin-6-amine Chemical compound C=1C=CC=CC=1CNC(C=1N=C2)=NC=NC=1N2C1CCCCO1 POFWRMVFWIJXHP-UHFFFAOYSA-N 0.000 description 1
210000004898 n-terminal fragment Anatomy 0.000 description 1
229960004927 neomycin Drugs 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
XXUPLYBCNPLTIW-UHFFFAOYSA-N octadec-7-ynoic acid Chemical compound CCCCCCCCCCC#CCCCCCC(O)=O XXUPLYBCNPLTIW-UHFFFAOYSA-N 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
210000000287 oocyte Anatomy 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
101150083254 ost4 gene Proteins 0.000 description 1
150000002972 pentoses Chemical class 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
239000003208 petroleum Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
230000003285 pharmacodynamic effect Effects 0.000 description 1
CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
230000027086 plasmid maintenance Effects 0.000 description 1
229920001308 poly(aminoacid) Polymers 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
239000000843 powder Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
238000003825 pressing Methods 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
238000000751 protein extraction Methods 0.000 description 1
230000012846 protein folding Effects 0.000 description 1
230000017854 proteolysis Effects 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
238000003259 recombinant expression Methods 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
229960000160 recombinant therapeutic protein Drugs 0.000 description 1
230000007115 recruitment Effects 0.000 description 1
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
230000007441 retrograde transport Effects 0.000 description 1
238000004366 reverse phase liquid chromatography Methods 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
210000003705 ribosome Anatomy 0.000 description 1
230000007017 scission Effects 0.000 description 1
238000012216 screening Methods 0.000 description 1
230000028327 secretion Effects 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
239000007787 solid Substances 0.000 description 1
230000028070 sporulation Effects 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
230000010473 stable expression Effects 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
FRGKKTITADJNOE-UHFFFAOYSA-N sulfanyloxyethane Chemical compound CCOS FRGKKTITADJNOE-UHFFFAOYSA-N 0.000 description 1
239000013589 supplement Substances 0.000 description 1
230000008093 supporting effect Effects 0.000 description 1
230000003319 supportive effect Effects 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
108020002982 thioesterase Proteins 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
230000009261 transgenic effect Effects 0.000 description 1
230000005945 translocation Effects 0.000 description 1
108091005703 transmembrane proteins Proteins 0.000 description 1
102000035160 transmembrane proteins Human genes 0.000 description 1
230000032895 transmembrane transport Effects 0.000 description 1
239000002753 trypsin inhibitor Substances 0.000 description 1
241000701161 unidentified adenovirus Species 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
229960005356 urokinase Drugs 0.000 description 1
230000002792 vascular Effects 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
239000003981 vehicle Substances 0.000 description 1
210000003501 vero cell Anatomy 0.000 description 1
239000013603 viral vector Substances 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
239000007222 ypd medium Substances 0.000 description 1